Associate Professor of Neurology, of Medicine (Medical Oncology) and of Neurosurgery and Clinical Program Leader, Brain Tumor Program, Smilow Cancer Hospital
Chemotherapy of primary brain tumors (high-grade gliomas, central nervous system lymphoma); neurological complications of brain cancer; general neurology; molecular markers of cancer.
Accepts New Patients? Yes
Patient Type: Adult
Accepts appointments from patients or physicians
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma (The “ACT IV” Study)